25 tirzepatide (1-25) Tirzepatide FAQ: 25 Real Questions

5 About the SELECT Trial SELECT (Semaglutide Effects on Cardiovascular Outcomes in People with Overweight or Obesity) was a multicenter, randomized, double-blind, placebo-controlled, event-driven superiority trial designed to evaluate the efficacy of Wegovy 2.4 mg versus placebo as an adjunct to cardiovascular standard of care for reducing the risk of major adverse cardiovascular events in people with established CVD with overweight or obesity with no prior history of diabetes

Tirzepatide is a compounded medication used in weight loss treatments

We perform a pre-treatment screening to ensure safety

Dehydration and electrolyte imbalances (particularly sodium, calcium, or magnesium) resulting from gastrointestinal side effects could theoretically affect nerve function, though this is less commonly reported

These mediators act synergistically as anti-inflammatory, i.e., resolvin E1, resolvin D1, and protectin D1 to all inhibit transendothelial migration of neutrophils preventing their infiltration at sites of inflammation